VIPR1 and gastritis: Furthermore, the expression of VIP, VIPR1, TAC, and TACR1 was analyzed in patients with chronic active gastritis, chronic inactive gastritis, no gastritis, or the control group; no significant difference was observed among the groups (Kruskal-Wallis; p > 0.05) (Figures 2(a) and 2(c)).